From
WebSite
The recent scandals related to metal-on-metal artificial hips or faulty silicone breast implants have strengthened the case for modernising current rules for medical devices.
On 7 March 2017, the Council adopted new EU rules improving the safety of medical devices for the benefit of patients while preserving a timely access to innovative healthcare solutions.
The two new EU regulations (MDD & IVDMDD):
-provide a stronger
mandate to independent notified bodies in their assessment of medical devices
before they can be placed on the market, and strengthen the oversight of these
bodies by national authorities; the new rules also ensure that notified bodies
meet the same high safety standards throughout the EU; these measures will improve
the safety of medical devices;
-improve the availability of clinical data on devices
and clearly set out manufacturers' responsibilities for the follow-up of the quality,
performance and safety of devices placed on the market; this will allow manufacturers to
react quickly in the event of concerns being raised and help them improve their devices
continuously on the basis of actual data;
-improve the traceability of medical devices
throughout the supply chain to the end-user or patient by using a unique
identification number; this will allow fast and effective measures to
be taken in the event of safety problems;
-set up a
central database to provide patients, healthcare professionals and the public
with comprehensive information on products available in the EU; this will
enable them to make better informed decisions.
Nessun commento:
Posta un commento
Nota. Solo i membri di questo blog possono postare un commento.